NO832184L - Fremgangsmaate for fremstilling av nye derivater av tioformamid - Google Patents
Fremgangsmaate for fremstilling av nye derivater av tioformamidInfo
- Publication number
- NO832184L NO832184L NO832184A NO832184A NO832184L NO 832184 L NO832184 L NO 832184L NO 832184 A NO832184 A NO 832184A NO 832184 A NO832184 A NO 832184A NO 832184 L NO832184 L NO 832184L
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- solution
- general formula
- ethyl acetate
- pyridyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 6
- -1 thieno[2,3-b]pyridin-5-yl Chemical group 0.000 claims abstract description 20
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical class NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 claims abstract description 3
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000012988 Dithioester Substances 0.000 claims description 8
- 125000005022 dithioester group Chemical group 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 5
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 34
- 229940030600 antihypertensive agent Drugs 0.000 abstract description 2
- 239000002220 antihypertensive agent Substances 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 125000004548 quinolin-3-yl group Chemical group N1=CC(=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 165
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 102
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 90
- 239000000203 mixture Substances 0.000 description 72
- 239000000243 solution Substances 0.000 description 70
- 239000000047 product Substances 0.000 description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 40
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 40
- 239000000741 silica gel Substances 0.000 description 40
- 229910002027 silica gel Inorganic materials 0.000 description 40
- 239000002904 solvent Substances 0.000 description 26
- 238000004809 thin layer chromatography Methods 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- 238000003756 stirring Methods 0.000 description 20
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 20
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 18
- 230000007935 neutral effect Effects 0.000 description 16
- 238000001914 filtration Methods 0.000 description 15
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 14
- 238000002844 melting Methods 0.000 description 14
- 230000008018 melting Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 239000000706 filtrate Substances 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N methyl ethyl ketone Substances CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 10
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 9
- 238000009835 boiling Methods 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003610 charcoal Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000003462 sulfoxides Chemical class 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- GKEMHVLBZNVZOI-MTATWXBHSA-N (2r)-n-methyl-1-oxo-2-pyridin-3-ylthiane-2-carbothioamide Chemical compound C=1C=CN=CC=1[C@@]1(C(=S)NC)CCCCS1=O GKEMHVLBZNVZOI-MTATWXBHSA-N 0.000 description 3
- YAXSVXNEQFGXSE-UHFFFAOYSA-N 2-pyridin-3-ylthiolane 1-oxide Chemical compound O=S1CCCC1C1=CC=CN=C1 YAXSVXNEQFGXSE-UHFFFAOYSA-N 0.000 description 3
- RBQCMEPOYAPQBU-UHFFFAOYSA-N 2-quinolin-3-ylthiane 1-oxide Chemical compound O=S1CCCCC1C1=CN=C(C=CC=C2)C2=C1 RBQCMEPOYAPQBU-UHFFFAOYSA-N 0.000 description 3
- HSURCYZHLJONAO-UHFFFAOYSA-N 3-(4-chlorobutylsulfanylmethyl)quinoline Chemical compound C1=CC=CC2=CC(CSCCCCCl)=CN=C21 HSURCYZHLJONAO-UHFFFAOYSA-N 0.000 description 3
- JECZLRYRMNGWNB-UHFFFAOYSA-N 3-(4-chlorobutylsulfinylmethyl)pyridine Chemical compound ClCCCCS(=O)CC1=CC=CN=C1 JECZLRYRMNGWNB-UHFFFAOYSA-N 0.000 description 3
- AYSFLIHMIPFKHN-UHFFFAOYSA-N 3-(4-chlorobutylsulfinylmethyl)quinoline Chemical compound C1=CC=CC2=CC(CS(=O)CCCCCl)=CN=C21 AYSFLIHMIPFKHN-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical group 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 125000005905 mesyloxy group Chemical group 0.000 description 3
- JVSUSYPPGOXUSP-UHFFFAOYSA-N methyl 1-oxo-2-pyridin-3-ylthiane-2-carbodithioate Chemical compound C=1C=CN=CC=1C1(C(=S)SC)CCCCS1=O JVSUSYPPGOXUSP-UHFFFAOYSA-N 0.000 description 3
- QAQSPYCGGLAYKF-UHFFFAOYSA-N methyl 1-oxo-2-pyridin-3-ylthiolane-2-carbodithioate Chemical compound C=1C=CN=CC=1C1(C(=S)SC)CCCS1=O QAQSPYCGGLAYKF-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JQQLRXCMJNLJCL-UHFFFAOYSA-N n-methyl-1-oxo-2-pyridin-3-ylthiolane-2-carbothioamide Chemical compound C=1C=CN=CC=1C1(C(=S)NC)CCCS1=O JQQLRXCMJNLJCL-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 150000003568 thioethers Chemical class 0.000 description 3
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 3
- VHPBYSDWVFDBAO-UHFFFAOYSA-N 3-(4-chlorobutylsulfanylmethyl)pyridine Chemical compound ClCCCCSCC1=CC=CN=C1 VHPBYSDWVFDBAO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 2
- AKXKDRAXEUJFHX-UHFFFAOYSA-N methyl 2-pyridin-3-ylthiane-2-carbodithioate Chemical compound C=1C=CN=CC=1C1(C(=S)SC)CCCCS1 AKXKDRAXEUJFHX-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- NIDSRGCVYOEDFW-UHFFFAOYSA-N 1-bromo-4-chlorobutane Chemical compound ClCCCCBr NIDSRGCVYOEDFW-UHFFFAOYSA-N 0.000 description 1
- YBQVLKIMKZFEIM-UHFFFAOYSA-N 1-oxo-2-pyridin-3-ylthiane-2-carbothioamide Chemical compound C=1C=CN=CC=1C1(C(=S)N)CCCCS1=O YBQVLKIMKZFEIM-UHFFFAOYSA-N 0.000 description 1
- YGUKHPCZRXRPIJ-UHFFFAOYSA-N 1-oxo-n-propan-2-yl-2-pyridin-3-ylthiane-2-carbothioamide Chemical compound C=1C=CN=CC=1C1(C(=S)NC(C)C)CCCCS1=O YGUKHPCZRXRPIJ-UHFFFAOYSA-N 0.000 description 1
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- UNDZTSGXNXEERW-UHFFFAOYSA-N 3-(thiolan-2-yl)pyridine Chemical compound C1CCSC1C1=CC=CN=C1 UNDZTSGXNXEERW-UHFFFAOYSA-N 0.000 description 1
- ZJAFQAPHWPSKRZ-UHFFFAOYSA-N 4-nitrobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=C([N+]([O-])=O)C=C1 ZJAFQAPHWPSKRZ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical compound OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- RFKVPWIRGWYWII-UHFFFAOYSA-N n-methyl-1-oxo-2-quinolin-3-ylthiane-2-carbothioamide Chemical compound C=1N=C2C=CC=CC2=CC=1C1(C(=S)NC)CCCCS1=O RFKVPWIRGWYWII-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- BBTQILBUDSANDJ-UHFFFAOYSA-N quinolin-3-ylmethyl carbamimidothioate Chemical compound C1=CC=CC2=CC(CSC(=N)N)=CN=C21 BBTQILBUDSANDJ-UHFFFAOYSA-N 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Primary Cells (AREA)
- Secondary Cells (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8210614A FR2528849B1 (fr) | 1982-06-17 | 1982-06-17 | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
NO832184L true NO832184L (no) | 1983-12-19 |
Family
ID=9275117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO832184A NO832184L (no) | 1982-06-17 | 1983-06-16 | Fremgangsmaate for fremstilling av nye derivater av tioformamid |
Country Status (25)
Country | Link |
---|---|
US (2) | US4568682A (da) |
EP (1) | EP0097584B1 (da) |
JP (1) | JPS597188A (da) |
KR (1) | KR840005137A (da) |
AT (1) | ATE19080T1 (da) |
AU (1) | AU562629B2 (da) |
CA (1) | CA1209138A (da) |
CS (1) | CS236886B2 (da) |
DD (1) | DD210043A5 (da) |
DE (1) | DE3362906D1 (da) |
DK (1) | DK156477C (da) |
ES (1) | ES8403912A1 (da) |
FI (1) | FI831648L (da) |
FR (1) | FR2528849B1 (da) |
GR (1) | GR79209B (da) |
IE (1) | IE55431B1 (da) |
IL (1) | IL69006A0 (da) |
MA (1) | MA19817A1 (da) |
NO (1) | NO832184L (da) |
NZ (1) | NZ204614A (da) |
OA (2) | OA07449A (da) |
PH (1) | PH19061A (da) |
PL (1) | PL242538A1 (da) |
PT (1) | PT76868B (da) |
ZA (1) | ZA834439B (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2528849B1 (fr) * | 1982-06-17 | 1985-06-21 | Rhone Poulenc Sante | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
JPS60181866U (ja) * | 1984-05-14 | 1985-12-03 | ミサワホ−ム株式会社 | 同軸ケ−ブル接続端子 |
FR2573428B1 (fr) * | 1984-11-20 | 1987-01-30 | Rhone Poulenc Sante | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
FR2653770B1 (fr) * | 1989-10-31 | 1992-01-03 | Rhone Poulenc Sante | Procede de preparation de (pyridyl-3)-2 tetrahydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r), les (pyridyl-3)-2 tetrhydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r) ainsi obtenus et les compositions pharmaceutiques qui les contiennent. |
FR2653662B1 (fr) * | 1989-10-31 | 1994-05-13 | Rhone Poulenc Sante | Application du n-methyl (pyridyl-3)-2 tetrahydrothiopyranne-carbothioamide-2-oxyde-1 a la preparation de medicaments destines au traitement de l'insuffisance coronarienne. |
JPH04211048A (ja) * | 1990-03-05 | 1992-08-03 | Mitsubishi Kasei Corp | チオカルバモイルアセトニトリル誘導体 |
JPH0473463U (da) * | 1990-11-01 | 1992-06-26 | ||
GB9314133D0 (en) * | 1993-07-08 | 1993-08-18 | Rhone Poulenc Rorer Ltd | New process |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4277484A (en) * | 1978-09-20 | 1981-07-07 | Ciba-Geigy Corporation | 1-Benzothiepin-4-carboxamides |
IE49570B1 (en) * | 1979-03-30 | 1985-10-30 | Rhone Poulenc Ind | 2-(pyrid-2-yl)tetrahydrothiophene derivatives |
FR2452488A1 (fr) * | 1979-03-30 | 1980-10-24 | Rhone Poulenc Ind | Nouveaux derives du (pyridyl-2)-2 tetrahydrothiophene, leur preparation et les medicaments qui les contiennent |
FR2488609A1 (fr) * | 1980-08-18 | 1982-02-19 | Rhone Poulenc Ind | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
EP0048304B1 (en) * | 1980-09-24 | 1984-12-19 | Black & Decker Inc. | Depth of cut adjustment mechanism for a power planer |
FR2511371A1 (fr) * | 1981-08-11 | 1983-02-18 | Rhone Poulenc Sante | Nouveaux nitriles heterocycliques, leur preparation et leur utilisation pour la preparation de medicaments |
FR2528849B1 (fr) * | 1982-06-17 | 1985-06-21 | Rhone Poulenc Sante | Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent |
-
1982
- 1982-06-17 FR FR8210614A patent/FR2528849B1/fr not_active Expired
-
1983
- 1983-05-11 FI FI831648A patent/FI831648L/fi not_active Application Discontinuation
- 1983-06-01 OA OA58016BISD patent/OA07449A/xx unknown
- 1983-06-01 OA OA58016TERA patent/OA07450A/xx unknown
- 1983-06-14 CS CS834303A patent/CS236886B2/cs unknown
- 1983-06-14 PT PT76868A patent/PT76868B/pt not_active IP Right Cessation
- 1983-06-15 IL IL69006A patent/IL69006A0/xx unknown
- 1983-06-15 PL PL24253883A patent/PL242538A1/xx unknown
- 1983-06-16 NO NO832184A patent/NO832184L/no unknown
- 1983-06-16 ZA ZA834439A patent/ZA834439B/xx unknown
- 1983-06-16 US US06/504,789 patent/US4568682A/en not_active Expired - Fee Related
- 1983-06-16 IE IE1424/83A patent/IE55431B1/en not_active IP Right Cessation
- 1983-06-16 EP EP83401241A patent/EP0097584B1/fr not_active Expired
- 1983-06-16 GR GR71699A patent/GR79209B/el unknown
- 1983-06-16 AT AT83401241T patent/ATE19080T1/de active
- 1983-06-16 CA CA000430581A patent/CA1209138A/fr not_active Expired
- 1983-06-16 DK DK277683A patent/DK156477C/da active
- 1983-06-16 AU AU15826/83A patent/AU562629B2/en not_active Ceased
- 1983-06-16 DE DE8383401241T patent/DE3362906D1/de not_active Expired
- 1983-06-16 DD DD83252092A patent/DD210043A5/de unknown
- 1983-06-16 KR KR1019830002691A patent/KR840005137A/ko not_active Application Discontinuation
- 1983-06-16 PH PH29063A patent/PH19061A/en unknown
- 1983-06-16 MA MA20039A patent/MA19817A1/fr unknown
- 1983-06-16 JP JP58106818A patent/JPS597188A/ja active Granted
- 1983-06-17 ES ES523387A patent/ES8403912A1/es not_active Expired
- 1983-06-26 NZ NZ204614A patent/NZ204614A/en unknown
-
1985
- 1985-08-16 US US06/766,199 patent/US4751234A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU782114B2 (en) | Quinuclidine compounds and drugs containing the same as the active ingredient | |
CA2135160A1 (en) | Indole derivative | |
CN102702044A (zh) | 作为γ分泌酶抑制剂的碳环和杂环芳基砜化合物 | |
NO170583B (no) | Analogifremgangsmaate for fremstilling av nye derivater av1h,3h-pyrrolo-(1,2-c)-tiazol | |
US5157129A (en) | Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide | |
NO832184L (no) | Fremgangsmaate for fremstilling av nye derivater av tioformamid | |
NO170419B (no) | Analogifremgangsmaate for fremstilling av 1h,3h-pyrrolo-(1,2-c)-tiazolderivater | |
NO167204B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diacylderivater av 4-(trialkylbenzyl)-piperazinylforbindelser. | |
FI66862B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-(pyridyl-2)-tetrahydrotiofenderivat | |
CA3049192A1 (en) | Tetrahydroquinoline derivatives as p2x7 receptor antagonists | |
Miyamoto et al. | Synthesis and reactions of 7‐substituted 1‐cyclopropyl‐6‐fluoro‐1, 4‐dihydro‐4‐oxo‐1, 8‐naphthyridine‐3‐carboxylic acids as an antibacterial agent | |
NO810962L (no) | Fremgangsmaate for fremstilling av nye derivater av tioformamid | |
AU2023209523A1 (en) | Aromatic fused ring nav1.8 inhibitor, and use thereof | |
EP0326297B1 (en) | Thioformamide derivatives | |
US4888338A (en) | 5-Methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes as anti-PAF agents | |
NO781712L (no) | Fremgangsmaate for fremstilling av nye derivater av 4-hydroksytiazolidin-2-tion | |
EP0073704A1 (fr) | Nouveaux nitriles hétérocycliques, leur préparation et leur utilisation pour la préparation de médicaments | |
NO783770L (no) | Nye derivater av isokinolin. | |
EP2460803A1 (en) | Method for producing thiabenzoazulene propionic acid derivative | |
Blank et al. | Synthesis and hypoglycemic activity of 4-substituted 3-mercaptopicolinic acids | |
NO301012B1 (no) | Fremgangsmåte for fremstilling av benzo£b|naftyridiner | |
CA3198571A1 (en) | A pyrrole derivative, its preparation method and use | |
CN113735821A (zh) | 3-取代异硫香豆素衍生物的合成方法 | |
DK169681B1 (da) | Fremgangsmåde til fremstilling af pristinamycin IIB-derivater | |
KR100247561B1 (ko) | 신규한 피리디닐메틸아민 유도체와 그 제조방법 및 이를 함유하는 약제조성물 |